Pluri Inc. Accounts Payable and Other Accrued Liabilities, Current
Pluri Inc. (PLUR) had Accounts Payable and Other Accrued Liabilities, Current of $1.01 million as of 2024-06-30, per its 10-K filed 2024-09-18.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2024-09-18
- 2024-06-30: Accounts Payable and Other Accrued Liabilities, Current $1.01M.
- 2024-03-31: Accounts Payable and Other Accrued Liabilities, Current $952.00K.
- 2023-12-31: Accounts Payable and Other Accrued Liabilities, Current $981.00K.
- 2023-09-30: Accounts Payable and Other Accrued Liabilities, Current $993.00K.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2024-06-30 | $1.01M 10-K · filed 2024-09-18 | |
| 2024-03-31 | $952.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $981.00K 10-Q · filed 2024-02-12 | |
| 2023-09-30 | $993.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.10M 10-K · filed 2024-09-18 | |
| 2023-03-31 | $1.15M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.10M 10-Q · filed 2023-02-13 | |
| 2022-09-30 | $1.29M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.74M 10-Q · filed 2023-05-09 | |
| 2022-03-31 | $1.55M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.45M 10-Q · filed 2022-02-07 | |
| 2021-09-30 | $1.42M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $1.21M 10-K · filed 2022-09-21 | $2.42M 10-K · filed 2021-09-13 |
| 2021-03-31 | $2.19M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.27M 10-Q · filed 2021-02-08 | |
| 2020-09-30 | $1.98M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.98M 10-K · filed 2021-09-13 | |
| 2019-06-30 | $2.13M 10-K · filed 2020-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |